Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
Search by expertise, name or affiliation
Conversion to sirolimus with calcineurin inhibitor elimination vs. dose minimization and renal outcome in heart and lung transplant recipients
Sevag Demirjian
, B. Stephany
, I. S. Abu Romeh
,
M. Boumitri
, M. H. Yamani
, E. D. Poggio
Medicine - Renal and Hypertension Division
Research output
:
Contribution to journal
›
Article
›
peer-review
17
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Conversion to sirolimus with calcineurin inhibitor elimination vs. dose minimization and renal outcome in heart and lung transplant recipients'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Calcineurin Inhibitor Withdrawal
14%
Calcineurin Inhibitors
100%
Confounding Variables
14%
Cyclosporine
14%
Dose Reduction
14%
Estimated Glomerular Filtration Rate
42%
Heart Transplant Recipients
100%
Immunosuppression
14%
Inhibitor Therapy
14%
Lung Transplantation
100%
Overall Survival
14%
Patient Survival
14%
Renal Outcome
100%
Renal Transplant Recipients
14%
Repeated Measures ANOVA
14%
Sirolimus
100%
Tacrolimus
14%
Medicine and Dentistry
Analysis of Variance
14%
Calcineurin Inhibitor
100%
Cyclosporine
14%
Drug Dose Reduction
14%
Glomerular Filtration Rate
42%
Heart Graft
100%
Immunosuppressant
14%
Immunosuppressive Treatment
14%
Lung Transplantation
100%
Overall Survival
14%
Rapamycin
100%
Tacrolimus
14%